Neuroblastoma-specific expression of potential therapeutics cannot be achieved using a promoter region of the NCX (TLX2) gene
- PMID: 20094074
- PMCID: PMC2943140
- DOI: 10.1038/cgt.2009.90
Neuroblastoma-specific expression of potential therapeutics cannot be achieved using a promoter region of the NCX (TLX2) gene
Figures

Comment on
-
Tissue-specific expression of a suicide gene for selective killing of neuroblastoma cells using a promoter region of the NCX gene.Cancer Gene Ther. 2001 Dec;8(12):997-1002. doi: 10.1038/sj.cgt.7700408. Cancer Gene Ther. 2001. PMID: 11781663
References
-
- Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer. 2003;3(3):203–216. - PubMed
-
- Narita M, Bahar R, Hatano M, Kang MM, Tokuhisa T, Goto S, Saisho H, Sakiyama S, Tagawa M. Tissue-specific expression of a suicide gene for selective killing of neuroblastoma cells using a promoter region of the NCX gene. Cancer Gene Ther. 2001;8(12):997–1002. - PubMed
-
- Rao MK, Wilkinson MF. Tissue-specific and cell type-specific RNA interference in vivo. Nat Protoc. 2006;1(3):1494–1501. - PubMed
-
- Yang W, Paschen W. Conditional gene silencing in mammalian cells mediated by a stress-inducible promoter. Biochem. Biophys. Res. Commun. 2008;365(3):521–527. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical